Cervical Cancer

Showing 1-8 of 9 results

Research roundup: October 2025 edition

DMPA on TikTok, OTC pill sales, Misoprostol & IUD placements, Telehealth abortion & TGD populations, Abortion restrictions & infant mortality

Research roundup: September 2025 edition

Contraceptive knowledge gaps, Adolescent awareness of OTC contraception, DMPA and meningioma risk, Implicit bias in contraception counseling, PrEP & STI Risk

HPV Self-Collection: A New Option in Your Toolkit

HPV self-collection is here. FDA-approved in 2024, self-swabbing lets many patients collect their own sample in the clinic, offering a safe, evidence-based option to expand cervical cancer screening access and support patient-centered care.

Research roundup: August 2025 edition

HPV self-collection, asynchronous telehealth abortion studies, young people and permanent contraception access, clinician confidence gaps in abortion navigation, shifting contraceptive preferences postpartum

Clinical scenario: Managing abnormal cervical cancer screening tests

What providers need to know about putting the 2019 ASCCP Risk-Based Management Consensus Guidelines into practice

Research roundup: October 2024 edition

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Research roundup: May 2022 edition

Zinc supplements to help clear cervical HPV, unmet needs for reproductive health care in primary care settings, distance related barriers to abortion access, and more.

Research roundup: November 2021 edition

Intracervical block vs naproxen for pain during IUD insertion, IUD use in transgender and gender-diverse individuals, self-administration of the Depo shot, and more.
  • Previous
  • 1(current)
  • 2
  • Next